[
    [
        {
            "time": "2023-02-24",
            "original_text": "A股共发生97宗大宗交易成交38.5亿元（2月24日）",
            "features": {
                "keywords": [
                    "A股",
                    "大宗交易",
                    "成交额"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "全市场"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "A股共发生97宗大宗交易成交38.5亿元（2月24日）",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 4,
                "Entity_Density": 1,
                "Market_Scope": 9,
                "Time_Proximity": 10,
                "Headline_Structure": 7,
                "Source_Recency": 10
            }
        },
        {
            "time": "2023-02-24",
            "original_text": "康龙化成现1笔大宗交易 共成交1,020.24万元",
            "features": {
                "keywords": [
                    "康龙化成",
                    "大宗交易",
                    "成交额"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "康龙化成现1笔大宗交易 共成交1,020.24万元",
                "Correlation": 10,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 3,
                "Entity_Density": 10,
                "Market_Scope": 2,
                "Time_Proximity": 10,
                "Headline_Structure": 6,
                "Source_Recency": 10
            }
        },
        {
            "time": "2023-02-24",
            "original_text": "康龙化成今日大宗交易成交18万股，成交价56.68元折价8.65%",
            "features": {
                "keywords": [
                    "康龙化成",
                    "大宗交易",
                    "折价率"
                ],
                "sentiment_score": 0.4,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "康龙化成今日大宗交易成交18万股，成交价56.68元折价8.65%",
                "Correlation": 10,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 6,
                "Duration": 3,
                "Entity_Density": 10,
                "Market_Scope": 2,
                "Time_Proximity": 10,
                "Headline_Structure": 7,
                "Source_Recency": 10
            }
        },
        {
            "time": "2023-02-24",
            "original_text": "CRO公司将受益于整个行业成长大背景，发展空间被看好",
            "features": {
                "keywords": [
                    "CRO",
                    "行业成长",
                    "发展空间"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "CRO公司将受益于整个行业成长大背景，发展空间被看好",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 10,
                "Headline_Structure": 8,
                "Source_Recency": 10
            }
        },
        {
            "time": "2023-02-24",
            "original_text": "巨丰数据赢｜大股东持股数据 “国资”举牌目标再次出现",
            "features": {
                "keywords": [
                    "大股东",
                    "持股数据",
                    "国资举牌"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "全市场"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "巨丰数据赢｜大股东持股数据 “国资”举牌目标再次出现",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 5,
                "Market_Scope": 4,
                "Time_Proximity": 10,
                "Headline_Structure": 7,
                "Source_Recency": 10
            }
        },
        {
            "time": "2019",
            "original_text": "2019年，国内创新生物医药企业扎堆在港股IPO",
            "features": {
                "keywords": [
                    "创新生物医药",
                    "港股IPO"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "2019年，国内创新生物医药企业扎堆在港股IPO",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 6,
                "Time_Proximity": 10,
                "Headline_Structure": 6,
                "Source_Recency": 10
            }
        },
        {
            "time": "2023-02-24",
            "original_text": "智通港股通占比异动统计|2月24日",
            "features": {
                "keywords": [
                    "港股通",
                    "占比异动",
                    "统计"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "全市场"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "智通港股通占比异动统计|2月24日",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 4,
                "Impact": 3,
                "Duration": 4,
                "Entity_Density": 1,
                "Market_Scope": 7,
                "Time_Proximity": 10,
                "Headline_Structure": 5,
                "Source_Recency": 10
            }
        }
    ]
]